While the roles of protein conformational dynamics and allostery in protein function are well-23 accepted concepts, the roles of inter-domain dynamics in the structure-dynamics-function relation 24 of biomolecules are not yet completely understood. Here we show that inter-domain dynamics of 25 matrix metalloprotease-1 (MMP1) on fibrin are correlated with activity and can be modulated 26 using ligands. Using single-molecule Forster Resonance Energy Transfer (FRET), we determined 27 that the distance between the catalytic and hemopexin domains of MMP1 becomes larger/smaller 28 as the MMP1 activity becomes higher/lower. We modulated the activity using 1) a point mutation 29
1 collagen, stands out in the 23-member MMP family because it has crystal structure available 4 48 and its interaction with collagen monomers is well-studied 5-13 . MMP1 consists of a catalytic 49 domain that actually degrades substrates, a hemopexin domain that helps MMPs bind to the 50 substrates, and a linker that mediates communications between the two domains (Figure 1) . MMPs 51 are highly promiscuous, an attribute that we previously used to degrade E. coli proteins and 52 purified recombinant MMP1 using a protease-based method 14 . The promiscuity of MMPs is 53
intriguing because the catalytic domain sequence is largely conserved across the MMP family, 54
whereas the hemopexin domain sequence varies 15, 16 . Indeed, the hemopexin domain has been 55
shown to influence substrate/ligand specificity and activation/inhibition of various MMPs 17 and 56 regulation of MMP1 catalytic activity by the hemopexin domain has been reported 6 . These results 57 suggest that differences in activity and substrate specificity among MMPs are likely caused by 58 allosteric (far from the catalytic site) communications from other domains. Recently, we showed 59 that inter-domain dynamics of MMP1 on collagen fibrils correlate with activity and the two 60 domains can allosterically communicate via the linker region as well as the substrate. 61
In this paper, we focus on MMP1 inter-domain dynamics on 62 fibrin, the primary component of a blood clot. Fibrin is an 63 important physiological substrate because ~900000 patients 64 are diagnosed with complications from clot formation 65 leading to ~300,000 deaths 18 and ~$28 billion annual cost 19 66 in the US alone. The number of adults with clot-related 67
complications is estimated to reach ~1.82 million by 2050 20 . 68 Blood clot formation through the coagulation cascade is a 69 part of the natural response to injury and cut and prevents 70 loss of blood from severed blood vessels 21 . The life-saving 71 process of clot formation can become life-threatening if a 72 blood vessel is blocked due to a clot. Indeed, pathologies of 73 clot formation include heart attack, stroke, and pulmonary 74 embolism account for ~50% of all hospital deaths. 75 Reperfusion, the act of restoring blood flow, with tissue 76 plasminogen activator (tPA) remains the gold standard 77 treatment for ischemic stroke 22 . However, initiating tPA 78 treatment after 3-4.5 hr of stroke onset can lead to adverse 79 side effects, notably, hemorrhagic transformation (HT). 80
Therefore, it is important to explore alternative approaches that could either replace tPA treatment 81 or extend the time window for tPA perfusion beyond the current time frame 22 . The fibrinolytic 82 system provides a mechanism of clot lysis and consists of plasminogen, which is converted to the 83 active enzyme plasmin by tissue plasminogen activator (tPA) and urokinase plasminogen activator 84 (uPA), which in turn degrades fibrin clot. The fibrinolytic system may be inhibited by specific 85 plasminogen activator inhibitors (mainly PAI-1) or specific plasmin inhibitors (mainly α2-86 antiplasmin) or by thrombin-activatable fibrinolysis inhibitor (TAFI or procarboxypeptidase U). 87 inter-domain dynamics, we measured single molecule FRET (smFRET) between two dyes 111 attached to the catalytic and hemopexin domains of MMP1. To this end, we mutated S142 on the 112 catalytic domain and S366 on the hemopexin domain of MMP1 to cysteines to attach dyes using 113 maleimide chemistry. We selected a FRET pair, Alexa555 and Alexa647. 114 
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We would detect smFRET only when both C142 and C366 are labeled with different dyes. There 122 are also other potential complications. Photophysical properties of dyes depend on solution 123
conditions (pH, temperature, chemical composition, etc.) 36 , blinking due to transition into 124 metastable states 37,38 , and photobleaching due to reaction with oxygen in the excited state 39 . 125
Additionally, Alexa dyes attached by a flexible linker 40 and enzyme microenvironment around 126 dyes can change FRET 41 . The combined complexity of smFRET, solution conditions, and 127 simulations has been reported before 42 . To address the potential complications from labeling, we 128 compared the results for active (E219) and catalytically inactive point mutant (E219Q) MMP1. 129
Since active and inactive MMP1 will be affected equally by these complications, we can 130 distinguish the effects due to activity. Note that the amino acid E219 14 is the same as E200 4 , which 131 differs because we included the 19 residues of signaling peptide as well. In a previous publication, 132
we showed that the specific activities of labeled and unlabeled MMP1 were not affected by 133
labeling. Figure 2A shows the structures of fibrinogen and fibrin as well as a reconstructed model 134 of fibrin using these structures. Upon limited cleavage by thrombin, water-soluble fibrinogen self-135 assemble into water-insoluble fibrin. We measured MMP1 inter-domain dynamics on a thin layer 136 of water-insoluble fibrin in a flow cell using a Total Internal Reflection Fluorescence (TIRF) 137 microscope ( Figure 2B ) as described in our previous publications. 138 histogram) compared to inactive MMP1 (orange histogram). This observation suggests that the 150 two domains need to move from each other for activity. Therefore, low FRET should appear more 151 or less as MMP1 activity becomes more or less. To test, we used tetracycline that is known to 152 affect MMP1 activity 35 . As shown in Figure 3B , low FRET conformations are significantly 153 inhibited in the presence of tetracycline. Since correlated motions indicate a decrease in 154 conformational entropy and can affect kinetics and thermodynamics of biological processes 155
including catalysis 43 , we calculated autocorrelation function of MMP1 conformational dynamics 156 under different experimental conditions (Figures 3C and 3D) . Without any ligand, the correlation 157 of FRET trajectories for active MMP1 was than the correlation for inactive MMP1 (Figure 3C) . 158 In the presence of tetracycline, this trend was reversed and inactive MMP1 had longer time-159 correlation than active MMP1 (Figure 3D) . Taken together, these results strongly suggest that 160
inter-domain dynamics and activity of MMP1 are functionally related and allosteric in nature. In 161 addition, the presence of correlation in inter-domain dynamics means lower entropy (less 162 randomness) and as such, the observed correlation suggests an entropy-driven activity 163 The same experiment with catalytically inactive MMP1 with a point mutation E219Q at the 176 catalytic site degraded the and chains, but did not degrade the -chain ( Figure 4A , lane 4 177 from left). We used trypsin during MMP1 purification and trypsin is known to degrade fibrinogen; 178 therefore, any residual trypsin could potentially interfere with the results. To address this 179 possibility, we added 0.5 mg/mL trypsin inhibitor to all the reactions, which was sufficient to 180 inhibit 0.1 mg/mL trypsin (Figure 4A , lane 5 from left). Even though limited digestion of 181 fibrinogen by thrombin leads to fibrin, the longer digestion for 24 hr led to further degradation of 182 fibrinogen and the profile looked in between active and inactive MMP1 (Figure 4A , lane 6 from 183 left). However, Figure 4A did not reveal the sequence in which the three chains of fibrinogen were 184 degraded. To determine the sequence, we incubated fibrinogen with active MMP1 for varying 185 amounts of time. MMP1 completely degraded -chain and partially degraded -chain within 2 hr; 186 however, -chain took almost more than 6 hr to be degraded (Figure 4B) . After 8 hr, a primary 187 band at ~40 kD remained. Next, we tested the effects of MMP1 on fibrin morphology using SEM 188 (Figure 4C) , where the destruction of fibrin structures was visible for active MMP1. Similar thin 189 layers of fibrin morphologies were created for smFRET experiments. Overall, ensemble 190 experiments in Figure 4 showed that MMP1 has fibrinolytic activity on fibrinogen and fibrin, and 191
there was a specific sequence of degradation of the three chains. Both thrombin and trypsin cleave 192 the same Arg-Gly bonds in fibrinogen 44 . However, thrombin is highly specific and only four bonds 193
linking the fibrinopeptides to the rest of the fibrinogen molecule are rapidly hydrolyzed by 194 thrombin, whereas trypsin cleaves all peptide bonds in fibrinogen that follow arginine and lysine 44 . 195 In the highest inter-domain distance (Figure 5A, left panel) . For close conformation, we selected the 219 conformation in the crystal structure (Figure 5A, right panel) . 220 conformations are functionally relevant. To gain further insights, we calculated the distance 233 between every atom in the MMP1 and the three fibrin chains. We counted the number of distances 234 below 0.5 nm for the top 30 docking poses and calculated the mean and standard deviation ( Figure  235 5C). On average, MMP1 in open conformation showed the closest proximity to the -chain 236 (Figure 5C, left panel) and followed the experimentally observed sequence (Figure 4B) . In 237 contrast, the close conformation of MMP1 did not show any significant difference in proximity to 238 the three chains (Figure 5C, right 
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MMP1 efficiently degrades crosslinked fibrin. It is known that water-soluble fibrinogen 247 becomes water-insoluble crosslinked fibrin in the presence of factor XIII, thrombin, and CaCl2. 248
Thrombin converts fibrinogen to fibrin by cleaving both fibrinopeptide A and fibrinopeptide B and 249 exposing polymerization sites in the E region, which results in the soluble fibrin monomer 47 . Fibrin 250 monomers self-assemble into double-stranded protofibirls where the polymerization sites 251 noncovalently attach to the D regions of two other fibrin(ogen) molecules. Fibrin monomers in 252 each strand are arranged end to end, whereas monomers across the strands are arranged in a half-253 staggered overlap. The -chains of adjacent D regions in each strand is covalently attached by 254
isopeptide bonds, which are formed due to the activity of factor XIIIa and appear as a ~94 kDa 255 band in SDS PAGE under reducing conditions (Figure 6A) . Factor XIIIa can also catalyze 256 covalent isopeptide bonds between -chains; however, these reactions are relatively slower. As a 257 result, the band at ~66.5 kDa due to the -chains still appear in SDS PAGE (Figure 6A) . Since 258
factor XIIIa does not crosslink the -chains 48,49 , the band at ~52 kDa due to the -chains remains 259 unchanged in SDS PAGE of fibrinogen ( Figure 4A ) and crosslinked fibrin (Figure 6A) . As shown 260
in Figure 6B , active MMP1 degrades and dissolves water-insoluble crosslinked fibrin, which is 261 inhibited by inactive MMP1. Figure 6C shows the surface morphology of crosslinked fibrin 262 imaged using SEM. Treatment with active MMP1 resulted in a more porous structure of 263 crosslinked fibrin. 264
In summary, we have shown that MMP1 has fibrinolytic activity on fibrinogen, fibrin, and were used as the ligands. The centroid structure of each of the resulting clusters (maximum 30) 311
was considered as the representative docking solution for a cluster and the corresponding weighted 312 scores for the best coefficient were obtained for each solution. All different solutions were brought 313 to the same Cartesian space by aligning the reconstructed fibrin from each solution to a template 314 one using PyMOL. To analyze the accessibility of MMP1 from each of the docking solutions to 315 the different fibrin or fibrinogen chains, we counted the total number of times that any atom from 316 MMP1 was within 5 Angstrom distance from any atom from each of the chains. 317 318
Preparation of fibrin without and with crosslinks. We prepared fibrin without crosslinks by 319 adding 10 units of thrombin (Cayman chemical, Cat# 13188) to 50 g of fibrinogen (Cayman 320 chemical, Cat# 16088) and incubating at 37º C for 18 hr with 250 rpm shaking inside an incubator 321 (Thermo Fisher Scientific, MaxQ600). Preparation of crosslinked fibrin involved two additional 322 reagents: factor XIII (Abcam, Cat # ab62427) and CaCl2. Formation of crosslinked fibrin involves 323 activation of human factor XIII to active human factor XIIIa and fibrinogen (pro form) to fibrin 324 threads by thrombin, which in the presence of Ca ++ induces crosslinking to form crosslinked fibrin. 325 We added 10 units of thrombin to 2.5 µg of factor XIII in a 0.5 mL PCR tube, diluted with 10 mM 326
Phosphate Buffer Saline (PBS) (Sigma, Cat# P3813, pH 7.4) to a total reaction volume of 100 L, 327 and incubated at 37º C for 10 min. After incubation, we added 50 g of fibrinogen and 10 µL of 5 328 mM CaCl2, diluted with PBS buffer to a total reaction volume of 200 µL, and incubated at 37º C 329
for 15 min to obtain gel-like crosslinked fibrin. The surface morphology of fibrin was imaged 330 using a Phenom Pro Scanning Electron microscope. 331 332
Single-molecule measurements. Full-length recombinant MMPs were expressed in E. coli and 333 purified in activated form using a protease based purification method 14 . Purified MMP1 was 334 labeled with AlexaFluor555 (ThermoFisher Scientific, Cat# A20346, donor dye) and 335
AlexaFluor647 (ThermoFisher Scientific, Cat# A20347, acceptor dye) using maleimide chemistry. 336 1 mL of MMP1 at 1 mg/mL concentration was incubated with 20 µL of 1 mg/mL AlexaFluor555 337
and AlexaFluor647 for 1 hr in a 5 mL glass vial in a nitrogen environment to avoid oxidation of 338 the dyes. After incubation, we used a 30 kDa cut-off Amicon filter to remove free dyes from the 339 solution. We compared the specific activities of labeled and unlabeled MMP1 on the synthetic 340 substrate, MCA-Lys-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2, (R&D Systems, Cat# ES010) as 341 described before 14 . A thin layer of fibrin was created on a quartz slide similar to blood smear 342 protocol used in diagnostics 56 . Labeled MMP1 was excited at 532 nm inside a flow cell made from 343 double-sided tape sandwiched between the quartz slide and a glass coverslip using the evanescent 344 wave created at the interface of the quartz slide and sample in a Total Internal Reflection 345
Fluorescence (TIRF) Microscope as described before 57,58 . Alexa647 and Alexa555 emissions were 346 imaged by an EMCCD camera (Andor iXon). The two emission channels were superimposed 347 using a pairwise stitching plugin of ImageJ and the intensities from the two dyes were extracted 348 and analyzed using Matlab. 349 350 SDS PAGE. The degradation profile after fibrinolysis was analyzed using SDS-PAGE. We mixed 351 SDS PAGE loading buffer containing BME (Biorad, Cat# 610737) with each sample in a 1:1 (v/v) 352 ratio and incubated at 95º C for 10 min. The samples were loaded onto the wells of 8% The authors declare no competing financial interests.
